Thrombolytic TherapyStreptokinaseTissue Plasminogen ActivatorFibrinolytic AgentsMyocardial InfarctionPlasminogen ActivatorsAnistreplaseUrokinase-Type Plasminogen ActivatorStrokePulmonary EmbolismBrain IschemiaTreatment OutcomeHeparinCerebral HemorrhageMyocardial ReperfusionTime FactorsEmbolectomyThrombosisAcute DiseaseCoronary Care UnitsFibrinolysisHeart Rupture, Post-InfarctionIntracranial ThrombosisHemorrhageElectrocardiographyIntracranial HemorrhagesAngioplasty, Balloon, CoronaryFibrinolysinCarotid Artery ThrombosisInfusions, IntravenousProspective StudiesCoronary ThrombosisCoronary AngiographyEmergency Medical ServicesRecurrenceIntracranial Embolism and ThrombosisInjections, IntravenousRecombinant ProteinsVascular PatencyEmergenciesInfusions, Intra-ArterialTomography, X-Ray ComputedIntracranial EmbolismVenous ThrombosisCerebral InfarctionHirudin TherapyEmergency TreatmentAnticoagulantsCreatine KinaseEmergency Medical TechniciansRadionuclide VentriculographyRetrospective StudiesHospital MortalityInjections, Intra-ArterialThrombectomyReperfusionFibrinopeptide ACerebral AngiographyFollow-Up StudiesFibrinogenFibrinEye HemorrhagePatient SelectionNewfoundland and LabradorHeart RuptureRandomized Controlled Trials as TopicCatheterization, PeripheralStreptodornase and StreptokinaseSurvival AnalysisAspirinAngiographyEcchymosisPredictive Value of TestsInfarction, Middle Cerebral ArteryRisk FactorsCerebrovascular DisordersDrug Therapy, CombinationBlood CoagulationPrognosisArterial Occlusive DiseasesFibrin Fibrinogen Degradation ProductsHospitals, CommunityCardiac CatheterizationShock, CardiogenicVentricular Septal RupturePlasminogenInfarction, Anterior Cerebral ArteryRegistriesSurvival RateMultivariate AnalysisIliac VeinHemostasisVena Cava FiltersHirudinsThrombophlebitisCommunity MedicinePlatelet Aggregation InhibitorsEmbolismVentricular Dysfunction, RightVentricular Function, Left